In this issue:
Current updates on diagnosing and managing MS
Training reactive balance using trips and slips
Treatment of older patients with MS
Differential diagnosis of suspected MS
Global barriers to diagnosing MS
Cladribine added to PBAC meeting agenda
FDA approves first biosimilar to treat MS
MS treatments added to the WHO EML
Study on the use of MS clinical practice guidelines in Australia
Current MS clinical course descriptors need to change
Novel algorithm may help predict MS treatment adherence
COVID-19 resources
Conferences, workshops, and CPD
Please login below to download this issue (PDF)